Leuprolide

🧮 Dose calculator

Prostate cancer · Regimen source: FDA Lupron Depot · 2.1

• • Healthcare provider only; no fractional doses or combinations of depot products (different release). FDA Lupron Depot · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyDangerous / avoid

  Label: can cause fetal harm. Dangerous in pregnancy. FDA Lupron Depot · 8.1

  “Risk Summary Based on findings in animal studies and mechanism of action, LUPRON DEPOT may cause fetal harm when administered to a pregnant woman [see Clinical Pharmacology ( 12.1 )] .”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Lupron Depot · 8.2

  “The safety and efficacy of LUPRON DEPOT have not been established in females.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Lupron Depot · 8.4

  “See LUPRON DEPOT-PED ® (leuprolide acetate for depot suspension) labeling for the safety and effectiveness in children with central precocious puberty.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Lupron Depot · 8.5

  “In the clinical trials for LUPRON DEPOT in prostate cancer 80% of the subjects studied were at least 65 years of age.”

• ⚥ Females & males of reproductive potentialUse with caution

  Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Lupron Depot · 8.3

  “Infertility Males Based on findings in animals and mechanism of action, LUPRON DEPOT may impair fertility in males of reproductive potential [see Nonclinical Toxicology ( 13.1 )] .”